Genetic, anthropometric and metabolic features of adult norwegian patients with 21-hydroxylase deficiency

European Journal of Endocrinology

Volumn 167, Issue 4, 2012, Pages 507-516

  Nermoen, Ingrid ^a   Brønstad, Ingeborg ^b   Fougner, Kristian J ^c,d   Svartberg, Johan ^e,f   Øksnes, Marianne ^b,g   Husebye, Eystein S ^b,g   Løvås, Kristian ^b,g  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICOTROPIN; CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; HYDROXYPROGESTERONE; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; PRASTERONE SULFATE; PREDNISOLONE; SODIUM; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYP21A2 GENE; DIASTOLIC BLOOD PRESSURE; DNA SEQUENCE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE CONVERSION; GENE DELETION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NORWAY; OSTEOPENIA; POINT MUTATION; PRIORITY JOURNAL; SPLICING DEFECT; STEROID 21 MONOOXYGENASE DEFICIENCY; VITAMIN D DEFICIENCY;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; ANTHROPOMETRY; BLOOD PRESSURE; BODY WEIGHTS AND MEASURES; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; NORWAY; STEROID 21-HYDROXYLASE; YOUNG ADULT;

EID: 84866673213     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0196     Document Type: Article

References (46)

1. Speiser PW, Agdere L, Ueshiba H, White PC & New MI. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. New England Journal of Medicine 1991 324 145-149. (doi:10.1056/NEJM199101173240302)
2. Stikkelbroeck NM, Hoefsloot LH, de Wijs IJ, Otten BJ, Hermus AR & Sistermans EA. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. Journal of Clinical Endocrinology and Metabolism 2003 88 3852-3859. (doi:10.1210/jc.2002-021681)
3. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M & White PC. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 4133-4160. (doi:10.1210/jc.2009-2631)
4. Nermoen I, Rørvik J, Holmedal SH, Hykkerud DL, Fougner KJ, Svartberg J, Husebye ES & Løvås K. High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. Clinical Endocrinology 2011 75 753-759. (doi:10.1111/j.1365-2265. 2011.04151.x)
5. New MI. Factors determining final height in congenital adrenal hyperplasia. Journal of Pediatric Endocrinology and Metabolism 2001 14 933-937.
6. Bonfig W, Bechtold S, Schmidt H, Knorr D & Schwarz HP. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. Journal of Clinical Endocrinology and Metabolism 2007 92 1635-1639. (doi:10.1210/jc.2006-2109)
7. Hagenfeldt K, Martin RE, Ringertz H, Helleday J & Carlström K. Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. European Journal of Endocrinology/European Federation of Endocrine Societies 2000 143 667-671. (doi:10.1530/eje.0.1430667)
8. Stikkelbroeck NM, Oyen WJ, van der Wilt GJ, Hermus AR & Otten BJ. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2003 88 1036-1042. (doi:10.1210/jc.2002-021074)
9. Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL & Wark JD. Bone mineral density and body composition in congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1995 80 2238-2243. (doi:10.1210/jc.80.7.2238)
10. Young NR, Baker HW, Liu G & Seeman E. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. Journal of Clinical Endocrinology and Metabolism 1993 77 1028-1032. (doi:10.1210/jc.77.4.1028)
11. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K & Thoren M. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2007 92 4643-4649. (doi:10.1210/jc.2007-0744)
12. Koetz KR, Ventz M, Diederich S & Quinkler M. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. Journal of Clinical Endocrinology and Metabolism 2012 97 85-92. (doi:10.1210/jc.2011-2036)
13. Paganini C, Radetti G, Livieri C, Braga V, Migliavacca D & Adami S. Height, bone mineral density and bone markers in congenital adrenal hyperplasia. Hormone Research 2000 54 164-168. (doi:10.1159/000053253)
14. Mooij CF, Kroese JM, Claahsen-van der Grinten HL, Tack CJ & Hermus AR. Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? Clinical Endocrinology 2010 73 137-146. (doi:10.1111/j.1365-2265.2009.03690.x)
15. Falhammar H, Filipsson NH, Ekström U, Granberg S, Wedell A & Thoren M. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. European Journal of Endocrinology 2012 3 441-449. (doi:10.1530/EJE-11-0828)
16. Reisch N, Flade L, Scherr M, Rottenkolber M, Pedrosa GF, Bidlingmaier M, Wolff H, Schwarz HP, Quinkler M, Beuschlein F & Reincke M. High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 2009 94 1665-1670. (doi:10.1210/jc.2008- 1414)
17. Nermoen I, Husebye ES, Svartberg J & Løvås K. Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. European Journal of Endocrinology 2010 163 453-459. (doi:10.1530/EJE-10-0284)
18. Carel RS, Silverberg DS, Shoenfeld Y, Eldar M, Snir C & Mor G. Changes in blood pressure in the lying and sitting positions in normotensive, borderline and hypertensive subjects. American Journal of the Medical Sciences 1983 285 2-11. (doi:10.1097/00000441-198303000-00001)
19. Rivkees SA & Crawford JD. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 2000 106 767-773. (doi:10.1542/peds.106.4.767)
20. Ness-Jensen E, Lindam A, Lagergren J & Hveem K. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut, 2012. In press. (doi:10.1136/gutjnl-2011-300715)
21. Gjesdal CG, Aanderud SJ, Haga HJ, Brun JG & Tell GS. Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporosis International 2004 15 525-534. (doi:10.1007/s00198-003-1573-2)
22. Wedell A & Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Human Molecular Genetics 1993 2 499-504. (doi:10.1093/hmg/2.5.499)
23. Wilson RC, Wei JQ, Cheng KC, Mercado AB & New MI. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. Journal of Clinical Endocrinology and Metabolism 1995 80 1635-1640. (doi:10.1210/jc.80.5.1635)
24. Parajes S, Quinterio C, Dominguez F & Loidi L. A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency. Clinical Chemistry 2007 53 1577-1584. (doi:10.1373/clinchem.2007.087361)
25. Merke DP & Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005 365 2125-2136. (doi:10.1016/S0140-6736(05)66736-0)
26. Wedell A, Thilen A, Ritzen EM, Stengler B & Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. Journal of Clinical Endocrinology and Metabolism 1994 78 1145-1152. (doi:10.1210/jc.78.5.1145)
27. Wedell A. Anupdate on themolecular genetics of congenital adrenal hyperplasia: diagnostic and therapeutic aspects. Journal of Pediatric Endocrinology and Metabolism 1998 11 581-589. (doi:10.1515/JPEM.1998.11.5.581)
28. Wedell A, Ritzen EM, Haglund-Stengler B & Luthman H. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. PNAS 1992 89 7232-7236. (doi:10.1073/pnas.89.15.7232)
29. Volkl TM, Simm D, Beier C & Dorr HG. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 2006 117 e98-e105. (doi:10.1542/peds.2005-1005)
30. Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM & Ross RJ. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. Journal of Clinical Endocrinology and Metabolism 2010 95 5110-5121. (doi:10.1210/jc.2010-0917)
31. Christiansen P, Mølgaard C & Muller J. Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormone Research 2004 61 133-136. (doi:10.1159/000075588)
32. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjöld A, Hagenfeldt K & Thoren M. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 2007 92 110-116. (doi:10.1210/jc.2006-1350)
33. Falhammar H, Filipsson NH, Wedell A & Thoren M. Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. European Journal of Endocrinology 2011 164 285-293. (doi:10.1530/EJE-10-0877)
34. Franklin SS. The importance of diastolic blood pressure in predicting cardiovascular risk. Journal of the American Society of Hypertension 2007 1 82-93. (doi:10.1016/j.jash.2006.11.004)
35. Nebesio TD & Eugster EA. Observation of hypertension in children with 21-hydroxylase deficiency: a preliminary report. Endocrine 2006 30 279-282. (doi:10.1007/s12020-006-0005-4)
36. Mooij CF, Kroese JM, Sweep FC, Hermus AR & Tack CJ. Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profile. PLoS ONE 2011 6 e24204. (doi:10.1371/journal.pone.0024204)
37. Martinerie L, Viengchareun S, Delezoide AL, Jaubert F, Sinico M, Prevot S, Boileau P, Meduri G & Lombes M. Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates. Endocrinology 2009 150 4414-4424. (doi:10.1210/en.2008-1498)
38. Christensen MH, Lien EA, Hustad S & Almas B. Seasonal and age-related differences in serum 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone in patients from Western Norway. Scandinavian Journal of Clinical and Laboratory Investigation 2010 70 281-286. (doi:10.3109/ 00365511003797172)
39. Wortsman J, Matsuoka LY, Chen TC, Lu Z & Holick MF. Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition 2000 72 690-693.
40. Falhammar H & Thoren M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine 2012 41 355-373. (doi:10.1007/s12020- 011-9591-x)
41. Muthusamy K, Elamin MB, Smushkin G, Murad MH, Lampropulos JF, Elamin KB, Abu Elnour NO, Gallegos-Orozco JF, Fatourechi MM, Agrwal N, Lane MA, Albuquerque FN, Erwin PJ &Montori VM. Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis. Journal of Clinical Endocrinology and Metabolism 2010 95 4161-4172. (doi:10.1210/jc.2009- 2616)
42. Dauber A, Kellogg M & Majzoub JA. Monitoring of therapy in congenital adrenal hyperplasia. Clinical Chemistry 2010 56 1245-1251. (doi:10.1373/ clinchem.2010.146035)
43. Livingstone C & Collison M. Sex steroids and insulin resistance. Clinical Science 2002 102 151-166. (doi:10.1042/CS20010197)
44. Jones TH. Effects of testosterone on type 2 diabetes and components of the metabolic syndrome. Journal of Diabetes 2010 2 146-156. (doi:10.1111/j.1753- 0407.2010.00085.x)
45. Volkl TM, Simm D, Korner A, Rascher W, Kiess W, Kratzsch J & Dorr HG. Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency? European Journal of Endocrinology 2009 160 239-247. (doi:10.1530/EJE-08-0770)
46. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjold A, Hagenfeldt K & Thoren M. Increased liver enzymes in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Journal 2009 56 601-608. (doi:10.1507/endocrj.K08E-312)